3. Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, Woo HH, Te AE, Kaplan SA.
Benign prostatic hyperplasia. Nat Rev Dis Primers 2016; 2(1): 1-5.
4. Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C.
American Cancer Society guideline for the early detection of prostate cancer: update 2010. Cancer J Clin 2010; 60(2): 70-98.
9. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L.
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci 2002; 99(24): 15524-15529.
10. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL.
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Nat Acad Sci 2006; 103(7): 2257-2261.
11. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, Chin L.
The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007; 67(16): 7713-7722.
40. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, Yazdanbod A, Shokoohi B, Mashayekhi A, Arshi S, Majidpour A.
Cancer occurrence in Ardabil: Results of a population‐based Cancer Registry from Iran. Int J Cancer 2003; 107(1): 113-118.